Company Filing History:
Years Active: 2022
Title: Iryna Yuriyivna Saranchova: Innovator in Cancer Immunity Modulation
Introduction
Iryna Yuriyivna Saranchova is a prominent inventor based in Surrey, Canada. She has made significant contributions to the field of cancer research, particularly in the modulation of cancer immunity. Her innovative work has the potential to impact cancer treatment and prognosis significantly.
Latest Patents
Iryna holds a patent titled "Modulation of cancer immunity with type 2 innate lymphoid cells, interleukin 33, and/or interferon induced protein 44." This invention provides methods for modulating cancer immunity using type 2 innate lymphoid cells (IL-C2s), interleukin 33 (IL-33), IFI44, or a combination thereof. The patent also outlines methods for preventing tumor metastasis and cancer progression through therapies that incorporate these elements. Additionally, diagnostic methods for assessing cancer prognosis are included in her patent.
Career Highlights
Iryna is associated with Cava Healthcare Inc., where she applies her expertise in cancer research. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Iryna collaborates with Wilfred A Jefferies, a fellow researcher, to further enhance the impact of her work in cancer immunity.
Conclusion
Iryna Yuriyivna Saranchova is a trailblazer in the field of cancer immunity modulation, with her innovative patent paving the way for new therapeutic approaches. Her contributions are vital in the ongoing fight against cancer.